IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 2.080
-0.010 (-0.48%)
Nov 2, 2026, 5:24 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 309.32 million as of November 2, 2026. It is the 33,410th most valuable company in the world and the 455th biggest in Sweden. Its market cap has increased by 46.25% in one year.
Market Cap
309.32M
Enterprise Value
299.30M
Revenue
79.33M
Global Rank
Country Rank
#455 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 309.32M, a decrease of -25.10%. That is a compound annual growth rate of -2.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 309.32M | 84.86% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xspray Pharma AB | 559.52M |
| FluoGuide | 498.65M |
| Cantargia AB | 451.68M |
| Isofol Medical AB | 383.95M |
| Sprint Bioscience AB | 379.86M |
| Corline Biomedical AB | 371.09M |
| BioInvent International AB | 357.32M |
| Mendus AB | 352.63M |